The move is based on data showing Alunbrig’s superiority over crizotinib as first-line treatment of metastatic ALK+ NSCLC

The firm has begun enrolling patients in the Phase I portion of the trial

The Solidarity trial’s expert group will review all evidence available on the drug

Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable […]

Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as […]

The sites will be managed by the National Institute for Health Research (NIHR) and run by NHS trusts

10 million tests have so far have been secured in a ‘landmark deal’ with industry, including Roche Diagnostics […]

Tecentriq is the first and only immune checkpoint inhibitor which has been deemed a cost effective use of […]

Samsung will provide GSK with additional flexible capacity for large-scale biopharmaceutical product manufacturing

Updated Date: Fri, 15 May 2020 00:00:00 EDT